Survival in men diagnosed with castration resistant prostate cancer: A population-based observational study in Sweden.

被引：0
|
作者：
Aly, Markus
Schain, Frida
Leval, Amy
Liwing, Johan
Lawson, Joe
Vago, Emese
Nordstrom, Tobias
Gronberg, Henrik
Andersson, Therese M-L
Sjoland, Erik
Wang, Chen
Eloranta, Sandra
Akre, Olof
机构：
[1] Danderyd Hosp, Dept Clin Sci, Karolinska Inst, Danderyd, Sweden
[2] Janssen, Bromma, Sweden
[3] Med Affairs Janssen Nord, Stockholm, Sweden
[4] Janssen Res & Dev, Raritan, NJ USA
[5] Janssen, Budapest, Hungary
[6] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[7] Janssen, Raritan, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e16555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16555
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
    Aly, Markus
    Leval, Amy
    Schain, Frida
    Liwing, Johan
    Lawson, Joe
    Vago, Emese
    Nordstrom, Tobias
    Andersson, Therese M. -L.
    Sjoland, Erik
    Wang, Chen
    Eloranta, Sandra
    Akre, Olof
    SCANDINAVIAN JOURNAL OF UROLOGY, 2020, 54 (02) : 115 - 121
  • [2] Population-based study on use of chemotherapy in men with castration resistant prostate cancer
    Lissbrant, Ingela Franck
    Garmo, Hans
    Widmark, Anders
    Stattin, Par
    ACTA ONCOLOGICA, 2013, 52 (08) : 1593 - 1601
  • [3] DISEASE TRAJECTORIES AND OUTCOMES FOR MEN WITH CASTRATION RESISTANT PROSTATE CANCER BY USE OF NATION-WIDE POPULATION-BASED OBSERVATIONAL DATA
    Ventimiglia, Eugenio
    Bill-Axelson, Anna
    Aly, Markus
    Eklund, Martin
    Stattin, Par
    Garmo, Hans
    JOURNAL OF UROLOGY, 2022, 207 (05): : E255 - E255
  • [4] Disease trajectories and outcomes for men with castration resistant prostate cancer by use of nation-wide population-based observational data
    Ventimiglia, E.
    Bill-Axelson, A.
    Aly, M.
    Eklund, M.
    Stattin, P.
    Garmo, H.
    EUROPEAN UROLOGY, 2022, 81 : S792 - S793
  • [5] Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study
    Bratt, O
    Kristoffersson, U
    Lundgren, R
    Olsson, H
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (02) : 272 - 277
  • [6] POPULATION-BASED ANALYSIS OF TREATMENT TOXICITY AMONG MEN WITH CASTRATION-RESISTANT PROSTATE CANCER
    Nam, Robert
    Wallis, Christopher
    Saskin, Refik
    Bansal, Symron
    Emmenegger, Urban
    Satkunasivam, Raj
    JOURNAL OF UROLOGY, 2017, 197 (04): : E766 - E767
  • [7] Population-based analysis of treatment toxicity among men with castration-resistant prostate cancer
    Nam, Robert
    Wallis, Christopher J. D.
    Saskin, Refik
    Bansal, Symron
    Emmenegger, Urban
    Satkunasivam, Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [8] A comparison of prostate cancer survival in England, Norway and Sweden: A population-based study
    Holmberg, L.
    Robinson, D.
    Sandin, F.
    Bray, F.
    Linklater, K. M.
    Klint, A.
    Lambert, P. C.
    Adolfsson, J.
    Hamdy, F. C.
    Catto, J.
    Moller, H.
    CANCER EPIDEMIOLOGY, 2012, 36 (01) : E7 - E12
  • [9] USE OF CANCER DRUGS IN THE END-OF-LIFE IN MEN DYING OF CASTRATION-RESISTANT PROSTATE CANCER: POPULATION-BASED STUDY
    Hu, J.
    Aprikian, A.
    Vanhuyse, M.
    Dragomir, A.
    VALUE IN HEALTH, 2018, 21 : S56 - S56
  • [10] Population-based Analysis of Treatment Toxicity Among Men With Castration-resistant Prostate Cancer: A Phase IV Study
    Wallis, Christopher J. D.
    Satkunasivam, Raj
    Saskin, Refik
    Bansal, Symron
    Kulkarni, Girish S.
    Emmenegger, Urban
    Nam, Robert K.
    UROLOGY, 2018, 113 : 138 - 144
12345